PESCE, SILVIA
 Distribuzione geografica
Continente #
EU - Europa 8.064
AS - Asia 1.080
NA - Nord America 976
Continente sconosciuto - Info sul continente non disponibili 226
SA - Sud America 89
AF - Africa 20
OC - Oceania 2
Totale 10.457
Nazione #
IT - Italia 7.849
US - Stati Uniti d'America 911
SG - Singapore 380
CN - Cina 293
VN - Vietnam 205
BD - Bangladesh 113
FR - Francia 73
BR - Brasile 60
FI - Finlandia 39
HK - Hong Kong 38
CA - Canada 30
DE - Germania 24
GB - Regno Unito 23
JP - Giappone 16
MX - Messico 12
CH - Svizzera 10
AR - Argentina 9
EC - Ecuador 9
ES - Italia 7
IQ - Iraq 7
TR - Turchia 6
JM - Giamaica 5
NL - Olanda 5
ZA - Sudafrica 5
CO - Colombia 4
CR - Costa Rica 4
GT - Guatemala 4
PH - Filippine 4
PK - Pakistan 4
RU - Federazione Russa 4
BG - Bulgaria 3
CL - Cile 3
ID - Indonesia 3
TN - Tunisia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
IN - India 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
PL - Polonia 2
PR - Porto Rico 2
SI - Slovenia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
SE - Svezia 1
SO - Somalia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 10.231
Città #
Genova 3.908
Genoa 2.434
Rapallo 641
Vado Ligure 633
San Jose 254
Singapore 182
Ashburn 89
Beijing 63
Ho Chi Minh City 61
Lauterbourg 60
Hanoi 59
Milan 57
Helsinki 38
Hong Kong 34
Los Angeles 34
Council Bluffs 31
New York 26
Bordighera 25
Santa Clara 24
Frankfurt am Main 18
Dallas 15
Tokyo 14
Da Nang 13
Rome 13
Valenza 13
Chicago 11
Figino 11
Catania 9
Buffalo 8
Zurich 8
Boardman 7
Haiphong 7
Orem 7
Washington 7
Cardiff 6
City of London 6
Guayaquil 6
Mexico City 6
Miami 6
Montreal 6
Columbus 5
London 5
Phoenix 5
Tianjin 5
Toronto 5
Atlanta 4
Baghdad 4
Biên Hòa 4
Charlotte 4
Denver 4
Des Moines 4
Houston 4
Marseille 4
Messina 4
Minneapolis 4
Paris 4
Queens 4
San Antonio 4
San José 4
Stockton 4
São Paulo 4
Albuquerque 3
Basingstoke 3
Bologna 3
Brooklyn 3
Cambridge 3
Chieti 3
Galati Mamertino 3
Guatemala City 3
Hanover 3
Johannesburg 3
Lawrenceville 3
Manchester 3
Medellín 3
Nashville 3
Philadelphia 3
Piscataway 3
Richmond 3
Rovereto 3
Shanghai 3
Winnsboro 3
Addis Ababa 2
Amsterdam 2
Anchorage 2
Anderson 2
Ankara 2
Baltimore 2
Barcelona 2
Boydton 2
Brescia 2
Bắc Ninh 2
Calgary 2
Can Tho 2
Curitiba 2
Edmonton 2
Florence 2
Fuzhou 2
Greensboro 2
Grezzana 2
Hinesville 2
Totale 9.037
Nome #
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 256
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 236
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 223
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 221
NK/DC crosstalk in anti-viral response. 207
Bridging innate NK cell Functions with Adaptive Immunity. 206
Features of Memory-Like and PD-1+ Human NK Cell Subsets 205
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 205
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 193
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 188
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 187
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 185
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 185
NK cells and their receptors during viral infections. 183
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 183
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 180
Harnessing NK Cells for Cancer Treatment 178
Human NK cell response to pathogens 173
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 168
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 161
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 155
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 155
NK Cell-Based Immunotherapy in Colorectal Cancer 154
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 150
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 150
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 148
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 148
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 147
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 147
New Insights into Endometrial Cancer 144
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 143
TLR/NCR/KIR: Which One to Use and When? 143
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 141
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 139
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 139
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 137
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 137
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 133
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 132
Harnessing Immune Response in Acute Myeloid Leukemia 131
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 130
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 128
The NK/DC complot 128
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry 128
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 127
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 127
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 125
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors 123
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 122
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 118
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 115
NK cells to cure cancer 113
The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of Natural Cytotoxicity Receptors with eosinophil surface ligands 110
The NK/DC complot 106
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade 104
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art 101
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 100
Female Malignancies and Immunotherapy: What's New? 100
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 99
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 96
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts 95
Immunological Analysis of Oral Cytobrush Specimens for Early Detection of Oral Cancer Biomarkers: A Comprehensive Review 92
A CRISPR approach to manipulating NK cell receptor ligand expression in leukemic cells 92
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 87
Regolazione recettore mediata dell’Homing delle cellule NK umane 86
Neutrophilic priming of NK cells enhance the response to ensuing IL-12 stimulation 84
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 81
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 81
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection 78
NK/DC crosstalk in anti-viral response 77
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers 76
Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity 72
null 66
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 59
Natural killer cell impairment in ovarian clear cell carcinoma 57
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 47
Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study 34
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy 32
NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells 29
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 21
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer 15
Totale 10.457
Categoria #
all - tutte 33.288
article - articoli 27.134
book - libri 0
conference - conferenze 5.274
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 880
Totale 66.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022720 24 36 60 48 48 53 47 171 58 68 35 72
2022/2023777 86 68 6 74 107 120 2 66 143 8 84 13
2023/2024532 27 70 14 65 36 52 39 72 27 27 40 63
2024/20251.626 36 100 65 117 212 153 177 237 52 93 183 201
2025/20263.018 337 79 248 216 363 263 419 143 238 325 168 219
2026/2027418 418 0 0 0 0 0 0 0 0 0 0 0
Totale 10.457